Wu, M., Mai, J., Zhang, H., Zhang, G., Mao, J., Tang, Y., . . . Niu, J. Safety, pharmacokinetics, and antiviral efficacy of the novel capsid assembly modulator GST-HG141 in patients with chronic hepatitis B: A phase 1 trial with a randomized, placebo-controlled design. BMC.
Chicago Style (17th ed.) CitationWu, Min, et al. Safety, Pharmacokinetics, and Antiviral Efficacy of the Novel Capsid Assembly Modulator GST-HG141 in Patients with Chronic Hepatitis B: A Phase 1 Trial with a Randomized, Placebo-controlled Design. BMC.
MLA (9th ed.) CitationWu, Min, et al. Safety, Pharmacokinetics, and Antiviral Efficacy of the Novel Capsid Assembly Modulator GST-HG141 in Patients with Chronic Hepatitis B: A Phase 1 Trial with a Randomized, Placebo-controlled Design. BMC.
Warning: These citations may not always be 100% accurate.